Bone effects of dydrogesterone in ovariectomized rats: A biologic, histomorphometric, and densitometric study

Bone

Volumn 19, Issue 5 SUPPL., 1996, Pages 463-468

  Roux, C ^a   Kolta, S ^a   Chappard, C ^a   Morieux, C ^b   Dougados, M ^a   De Vernejoul, M C ^b  

^a Rene Descartes University ^*  (France)

^b CENTRE VIGGO PETERSEN   (France)

Author keywords

Dual energy X ray absorptiometry; Dydrogesterone; Osteoclast; Osteoporosis; Progesterone

Indexed keywords

ACID PHOSPHATASE; DYDROGESTERONE; ESTRADIOL; OSTEOCALCIN; PROGESTERONE;

ACID PHOSPHATASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; BONE ATROPHY; BONE DENSITY; BONE METABOLISM; CELL FUNCTION; CONTROLLED STUDY; CORTICAL BONE; DOSE RESPONSE; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTRADIOL BLOOD LEVEL; FEMALE; MORPHOMETRICS; NONHUMAN; ORAL DRUG ADMINISTRATION; OSTEOCLAST; OSTEOPOROSIS; OVARIECTOMY; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TRABECULAR BONE; UTERUS WEIGHT;

ANALYSIS OF VARIANCE; ANIMALS; BONE DENSITY; CELL COUNT; DISEASE MODELS, ANIMAL; DYDROGESTERONE; ESTRADIOL; FEMALE; FEMUR; HUMANS; OSTEOCLASTS; OSTEOPOROSIS, POSTMENOPAUSAL; OVARIECTOMY; PROGESTERONE CONGENERS; RATS; RATS, SPRAGUE-DAWLEY; TIBIA;

EID: 0029904986     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(96)00244-X     Document Type: Article

References (30)

1. Ammann, P., Rizzoli, R., Slosman, D., and Bonjour, J. P. Sequential and precise in vivo measurement of bone mineral density in rats using dual energy X-ray absorptiometry. J Bone Miner Res 7:311-316; 1992.
2. Ammann, P., Rizzoli, R., Caverzasio, J., Shigematsu, T., Slosman, D., and Bonjour, J.P. Effects of the bisphosphonate tiludronate on bone resorption, calcium balance, and bone mineral density. J Bone Miner Res 8:1491-1498; 1993.
3. Bain, S. D., Jensen, E., Celino, D. L., Bailey, M. C., Lantry, M. M., and Edwards, M. W. High dose gestagens modulate bone resorption and formation and enhance estrogen-induced endosteal bone formation in the ovariectomized mouse. J Bone Miner Res 8:219-230; 1993.
4. Barbagallo, M., Carbognani, A., Palummeri, E., Chiavarini, M., Pedrazzoni, M., Bracchi, P. G., and Passeri, M. The comparative effect of ovarian hormone administration on bone mineral status in oophorectomized rats. Bone 10:113-116; 1989.
5. Barengolts, E. L, Gajardo, H. F., Rosol, T. J., d'Anza, J. J., Pena, M. , Botsis, J., and Kukreja, S. C. Effects of progesterone on postovariectomy bone loss in aged rats. J Bone Miner Res 5:1143-1147; 1990.
6. Chen, H. K., Ke, H. Z., Jee, W. S. S., Ma, Y. F., Pirie, C. M., Simmons, H. A., and Thompson, D. D. Droloxifene prevents ovariectomy-induced bone loss in tibiae and femora of aged female rats: a dual energy X-ray absorptiometry and histomorphometric study. J Bone Miner Res 10:1256-1262; 1995.
7. Chen, T. L., Aronow, L., and Feldman, D. Glucocorticoid receptors and inhibition of bone cell growth in primary culture. Endocrinology 100:619-628; 1977.
8. Cohen-Solal, M. E., Morieux, C., and De Vernejoul, M. C. Relationship between the number of resorbing cells and the amount of resorbed bone in metabolic bone disorders. J Bone Miner Res 6:915-919; 1991.
9. Consensus Development Conference: Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 94:646-650; 1993.
10. Gallagher, J. C., Kable, W. T., and Goldgar, D. Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen. Am J Med 90:171-178; 1991.
11. Griffin, M. G., Kimble, R., Hopfer, W., and Pacifici, R. Dual energy X-ray absorptiometry of the rat: accuracy, precision, and measurement of bone loss. J Bone Miner Res 8:795-800; 1993.
12. Hagiwara, S., Lane, N., Engelke, K., Sebastian, A., Kimmel, D. B., and Genant, H. K. Precision and accuracy for rat whole body and femur bone mineral determination with dual X-ray absorptiometry. Bone Miner 22:57-68; 1993.
13. Hirvonen, E., Mälkönen, M., and Manninen, V. Effects of different progestogens on lipoproteins during post menopausal replacement therapy. N Engl J Med 304:360-363; 1981.
14. Kalu, D. N. The ovariectomized rat model of postmenopausal bone loss. Bone Miner 15:175-192; 1991.
15. Kalu, D. N., Salerno, E., Liu, C. C. Echon, R., Ray, M., Gaza-Zapata, M., and Hollis, B. W. A comparative study of the actions of tamoxifene, estrogen and progesterone in the ovariectomized rat. Bone Miner 15:109-124; 1991.
16. Listrat, V., Roux, C., Roudier, R., Debregeas. P., and Dougados, M. Evaluation of bone mass of small laboratory animals with dual energy X-ray absorptiometry: precision and accuracy. Osteoporosis, vol. 2. Copenhagen: Osteopress; 1990; 901-902.
17. Mitlak, B. H., Schoenfeld, D., and Neer, M. R. Accuracy, precision, and utility of spine and whole-skeleton mineral measurements by DXA in rats. J Bone Miner Res 9:119-126; 1994.
18. Orcel, P., Bielakoff, J., Modrowski, D., Miravet, L., and De Vernejoul, M. C. Cyclosporin A induces in vivo inhibition of resorption and stimulation of formation in rat bone. J Bone Miner Res 4:387-391; 1989.
19. Parfitt, M. M., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche. H., Meunier, P. J., Ott, S. M., and Recker, R. R. Bone histomorphometry standardization of nomenclature, symbols and units. J Bone Miner Res 2:595-610; 1987.
20. Prior, J. C. Progesterone as a bone-trophic hormone. Endocrine Rev 11:386-398; 1990.
21. Riis, B. J., Thomsen, K., Ström, V., and Christiansen, C. The effect of percutaneous estradiol and natural progesterone on post menopausal bone loss. Am J Obstet Gynecol 156:61-65; 1987.
22. Schlosberg, M., Movsowitz, C., Epstein, S., Ismail, F., Fallen, M. D., and Thomas, S. The effect of cyclosporin A administration and its withdrawal on bone mineral metabolism in the rat. Endocrinology 124:2179-2184; 1989.
23. Sievänen, H., Kannus, P., and Järvinen, M. Precision of measurement by dual energy X-ray absorptiometry of bone mineral density and content in rat hind limb in vitro. J Bone Miner Res 9:473-478; 1994.
24. Simmons, D. J., and Cummins, H. Effect of acetophenone derivatives of 16, 17 dihydroxyprogesterone on SR retention in rats and mice. Proc Soc Exp Biol Med 128:1102-1106; 1968.
25. Turner, R. T., Francis, R., Wakley, G. K., Evans, G. L. Progesterone regulates bone balance by antagonizing the inhibitory effects of estrogen on bone turnover [abstract 1037]. J Bone Miner Res 4(Suppl 1); 1989.
26. Verhaar, H. J. J., Damen, C. A., Duursma, S. A., and Scheven, B. A. A. A comparison of the action of progestins and estrogen on the growth and differentiation of normal adult human osteoblast-like cells in vitro. Bone 15:307-311; 1994.
27. Voetberg, G. A., Netelenbos, J. C., Kenemans, P., Peters-Muller, E. R. A., and Van de Weiger, P. H. M. Estrogen replacement therapy continously combined with four different dosages of dydrogesterone: effect on calcium and lipid metabolism. J Clin Endocrinol Metab 79:1465-1469; 1994.
28. Voigt, L. F., Weiss, N. S., Chu, J., Daling, J. R., McKnight, B., and Van Belle, G. Progestagen supplementation of exogenous estrogens and risk of endometrial cancer. Lancet 2:274-277; 1991.
29. Wronski, T. J., Cintron, M., and Dann, L. M. Temporal relationship between bone loss and increased bone turnover in ovariectomized rats. Calcif Tissue Int 43:179-183; 1988.
30. Wronski, T. J., Dann, L. M., Scott, K. S., and Crooke, L. R. Endocrine and pharmacological suppressors of bone turnover protect against osteopenia in ovariectomized rats. Endocrinology 125:810-815; 1989.